axiVEND

Founded in 2020, axiVEND operates in the digital health sector as a specialized distributor and service provider for microarray instrumentation. Its core business involves selling and supporting high-precision microarray spotters, readers, and label-free detection systems, while also offering contract spotting services to enable customers to develop tests without upfront capital investment. The company positions itself as a solutions provider, leveraging an extended network of experts to assist clients from development through to manufacturing. Its focus is on enabling multiplex testing for applications in diagnostics, biosensors, food analysis, and environmental monitoring.

Value-added reseller and integrator of third-party microarray spotting systems (M2-Automation), readers, and label-free detection systems (IRIS Kinetics), combined with contract spotting services.

axiVEND competes with other distributors of life science instruments and specialized contract research organizations offering microarray services. Direct competition may come from larger, broad-line liquid handling companies and from the in-house capabilities of large diagnostic manufacturers. Its differentiation lies in its focused expertise on microarray spotting and its integrated offering of specific partner technologies with hands-on development support.